To Evaluate Prevention Effect Of Everolimus and Low-dose Tacrolimus in Comparison With Standard-dose Tacrolimus Therapy With Mycophenolic Acid on the New Onset Diabetes Mellitus After Transplantation in the Renal Allograft Recipients
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary) ; Mycophenolic acid
- Indications Diabetes mellitus; Renal transplant rejection
- Focus Therapeutic Use
- Acronyms PROTECT
- Sponsors Novartis
- 22 Sep 2014 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record
- 17 Feb 2014 New trial record